Clinical Trial Update: Nonmyeloablative Haploidentical Transplant Followed by MLN9708 [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating nonmyeloablative haploidentical transplant followed by MLN9708 (ixazomib) in various hematologic malignancies completed with posted res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma
• Multiple Myeloma
• Myelodysplastic Syndrome

Drugs mentioned

• MLN9708 (ixazomib)

Snippet

Sponsor: Northside Hospital, Inc. | Conditions: Acute Leukemia, Chronic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2021-09-02